Literature DB >> 9227954

Acquired myasthenia gravis.

J M Massey1.   

Abstract

Myasthenia gravis, an antibody-mediated disorder of neuromuscular transmission that produces clinical weakness, may be ocular or generalized. Clinical diagnostic evaluation may be supplemented by electrophysiologic studies and antibody testing. Therapeutic options, including anticholinesterase inhibitors, immunosuppressive agents, plasmapheresis and thymectomy, are tailored for the individual patient. This article emphasizes the key aspects of the clinical evaluation, diagnosis, and therapy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9227954     DOI: 10.1016/s0733-8619(05)70335-2

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  1 in total

1.  Late onset generalized myasthenia gravis presenting with facial weakness and bulbar signs without extraocular muscle involvement.

Authors:  Laura Cucurachi; Luigi Cattaneo; Franco Gemignani; Giovanni Pavesi
Journal:  Neurol Sci       Date:  2009-05-30       Impact factor: 3.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.